source
- FDA begins review of Roche’s experimental multiple sclerosis pill fenebrutinibThe FDA has accepted Roche's application for fenebrutinib, an experimental oral therapy for multiple sclerosis, and has started a priority review. The review will evaluate the drug in both relapsi…
- Varda Space Industries secures $251 million Series D to develop drug manufacturing in orbitCalifornia startup Varda Space Industries announced it has closed a $251 million Series D financing round. The capital will be directed toward building and launching manufacturing facilities in lo…